These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 15275732

  • 1. 5-fluorouracil-based chemoradiation in unresectable pancreatic carcinoma: Phase I-II dose-escalation study.
    Morganti AG, Valentini V, Macchia G, Mattiucci GC, Costamagna G, Deodato F, Smaniotto D, Luzi S, Balducci M, Barbi S, Perri V, Trodella L, Cellini N.
    Int J Radiat Oncol Biol Phys; 2004 Aug 01; 59(5):1454-60. PubMed ID: 15275732
    [Abstract] [Full Text] [Related]

  • 2. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM).
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206
    [Abstract] [Full Text] [Related]

  • 3. Chemoradiation of unresectable pancreatic carcinoma: impact of pretreatment hemoglobin level on patterns of failure.
    Morganti AG, Forni F, Macchia G, Valentini V, Smaniotto D, Trodella L, Balducci M, Cellini N.
    Strahlenther Onkol; 2003 Feb 15; 179(2):87-92. PubMed ID: 12590318
    [Abstract] [Full Text] [Related]

  • 4. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ, Shakespeare TP, Tan LK, Goh BC, Cooper JS.
    Head Neck; 2004 May 15; 26(5):389-95. PubMed ID: 15122654
    [Abstract] [Full Text] [Related]

  • 5. Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma.
    Keene KS, Rich TA, Penberthy DR, Shepard RC, Adams R, Jones RS.
    Int J Radiat Oncol Biol Phys; 2005 May 01; 62(1):97-103. PubMed ID: 15850908
    [Abstract] [Full Text] [Related]

  • 6. Intraoperative and conformal external-beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinoma.
    Furuse J, Kinoshita T, Kawashima M, Ishii H, Nagase M, Konishi M, Nakagohri T, Inoue K, Ogino T, Ikeda H, Maru Y, Yoshino M.
    Cancer; 2003 Mar 01; 97(5):1346-52. PubMed ID: 12599244
    [Abstract] [Full Text] [Related]

  • 7. Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis.
    Valentini V, Morganti AG, Macchia G, Mantini G, Mattiucci GC, Brizi MG, Alfieri S, Bossola M, Pacelli F, Sofo L, Doglietto G, Cellini N.
    Int J Radiat Oncol Biol Phys; 2008 Mar 15; 70(4):1094-9. PubMed ID: 18313525
    [Abstract] [Full Text] [Related]

  • 8. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
    Bradley J, Graham MV, Winter K, Purdy JA, Komaki R, Roa WH, Ryu JK, Bosch W, Emami B.
    Int J Radiat Oncol Biol Phys; 2005 Feb 01; 61(2):318-28. PubMed ID: 15667949
    [Abstract] [Full Text] [Related]

  • 9. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness.
    Ferrigno R, Nakamura RA, Dos Santos Novaes PE, Pellizzon AC, Maia MA, Fogarolli RC, Salvajoli JV, Filho WJ, Lopes A.
    Int J Radiat Oncol Biol Phys; 2005 Mar 15; 61(4):1136-42. PubMed ID: 15752894
    [Abstract] [Full Text] [Related]

  • 10. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):427-36. PubMed ID: 15380576
    [Abstract] [Full Text] [Related]

  • 11. Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy.
    Zhang Z, Liao Z, Jin J, Ajani J, Chang JY, Jeter M, Guerrero T, Stevens CW, Swisher S, Ho L, Yao J, Allen P, Cox JD, Komaki R.
    Int J Radiat Oncol Biol Phys; 2005 Mar 01; 61(3):656-64. PubMed ID: 15708243
    [Abstract] [Full Text] [Related]

  • 12. Chemoradiation and brachytherapy in biliary tract carcinoma: long-term results.
    Deodato F, Clemente G, Mattiucci GC, Macchia G, Costamagna G, Giuliante F, Smaniotto D, Luzi S, Valentini V, Mutignani M, Nuzzo G, Cellini N, Morganti AG.
    Int J Radiat Oncol Biol Phys; 2006 Feb 01; 64(2):483-8. PubMed ID: 16242254
    [Abstract] [Full Text] [Related]

  • 13. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
    Kam MK, Teo PM, Chau RM, Cheung KY, Choi PH, Kwan WH, Leung SF, Zee B, Chan AT.
    Int J Radiat Oncol Biol Phys; 2004 Dec 01; 60(5):1440-50. PubMed ID: 15590175
    [Abstract] [Full Text] [Related]

  • 14. Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome.
    Milano MT, Chmura SJ, Garofalo MC, Rash C, Roeske JC, Connell PP, Kwon OH, Jani AB, Heimann R.
    Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):445-53. PubMed ID: 15145161
    [Abstract] [Full Text] [Related]

  • 15. Phase I/II trial of hyperfractionated accelerated chemoradiotherapy for unresectable advanced pancreatic cancer.
    Tsujie M, Nakamori S, Tanaka E, Nagano H, Umeshita K, Dono K, Sakon M, Inoue T, Inoue T, Monden M.
    Jpn J Clin Oncol; 2006 Aug 01; 36(8):504-10. PubMed ID: 16855011
    [Abstract] [Full Text] [Related]

  • 16. Is extended volume external beam radiation therapy covering the anastomotic site beneficial in post-esophagectomy high risk patients?
    Yu E, Dar R, Rodrigues GB, Stitt L, Videtic GM, Truong P, Tomiak A, Ash R, Brecevic E, Inculet R, Malthaner R, Vincent M, Craig I, Kocha W, Lefcoe M.
    Radiother Oncol; 2004 Nov 01; 73(2):141-8. PubMed ID: 15542160
    [Abstract] [Full Text] [Related]

  • 17. Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study.
    Al-Sukhun S, Zalupski MM, Ben-Josef E, Vaitkevicius VK, Philip PA, Soulen R, Weaver D, Adsay V, Heilbrun LK, Levin K, Forman JD, Shields AF.
    Am J Clin Oncol; 2003 Dec 01; 26(6):543-9. PubMed ID: 14663369
    [Abstract] [Full Text] [Related]

  • 18. Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: effect of dose escalation on pathologic complete response, local recurrence-free survival, disease-free survival, and overall survival.
    Wiltshire KL, Ward IG, Swallow C, Oza AM, Cummings B, Pond GR, Catton P, Kim J, Ringash J, Wong CS, Wong R, Siu LL, Moore M, Brierley J.
    Int J Radiat Oncol Biol Phys; 2006 Mar 01; 64(3):709-16. PubMed ID: 16242252
    [Abstract] [Full Text] [Related]

  • 19. Selective dose escalation of chemoradiotherapy for esophageal cancer: role of treatment intensification.
    Seung SK, Smith JW, Molendyk J, Bader SB, Phillips M, Regan J, Louie J, Soo E, Seligman M, Ruzich J, Skokan L, Ross HJ.
    Semin Oncol; 2004 Dec 01; 31(6 Suppl 18):13-9. PubMed ID: 15726517
    [Abstract] [Full Text] [Related]

  • 20. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
    Deniaud-Alexandre E, Touboul E, Tiret E, Sezeur A, Hannoun L, Houry S, Huguet F, Pène F, Parc R, Schlienger M.
    Cancer Radiother; 2006 Dec 01; 10(8):572-82. PubMed ID: 17110148
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.